Showing 1 - 7 results of 7 for search 'Jingdong Chao', query time: 0.02s Refine Results
  1. 1
    Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease

    Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease by Yifei Liu, Joakim Söderberg, Jingdong Chao

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family

    Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family by Amy S. Paller, Servando E. Marron, Diane Whalley, Lauren Nelson, Shanshan Qin, Jingdong Chao, Ashish Bansal, Chien‐Chia Chuang, Zhixiao Wang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years

    Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2-5 years by Yi Zhang, Jennifer L. Clegg, Shannon Keith, Shehan McFadden, Tara Symonds, Rajesh Kumar, Asif H. Khan, Siddhesh Kamat, Jingdong Chao

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use

    Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use by Mette Deleuran, Danielle Marcoux, Marjolein S. Bruin-Weller, Alan D. Irvine, Eulalia Baselga, Kangmo Ahn, Ana Paula Castro, Ashish Bansal, Jingdong Chao, Gaëlle Bégo-, Ana B. Rossi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis

    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis by Jonathan I. Silverberg, Eric L. Simpson, Mark Boguniewicz, Marjolein S. De Bruin-Weller, Peter Foley, Yoko Kataoka, Gaëlle Bégo-, Zhen Chen, Brad Shumel, Jingdong Chao, Ana B. Rossi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

    Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study by Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-, Bruno Martins, Eric Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Efficacy of dupilumab in moderate and severe atopic dermatitis

    Efficacy of dupilumab in moderate and severe atopic dermatitis by Stephan Weidinger, Eric L. Simpson, Jonathan I. Silverberg, Jochen Schmitt, Yael A. Leshem, Norito Katoh, Zhen Chen, Haixin Zhang, Brad Shumel, Ashish Bansal, Jingdong Chao, Yufang Lu, Ana B. Rossi, Alvina Abramova

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: